Background: The OneTouch Verio Reflect® (OTVR) meter provides advanced Color Range and Blood Sugar Mentor™ features that are complemented by the OneTouch Reveal® (OTR) app. We sought to provide evidence that these products support improved glycemic control.

Methods: Anonymous glucose and app analytics were extracted from our server for 1627 people with type 1 diabetes (T1D) and 5353 people with type 2 diabetes (T2D) . Data from their first 14 days was compared to 14 days prior to a 180 day timepoint using paired within-subject differences.

Results: Percentage glucose readings in-range (70-180mg/dl) improved by 6.0% (from 58.9 to 64.8%) in T1Ds and by 10.7% (from 73.2 to 83.9%) in T2Ds. Hyperglycemic readings (>180mg/dl) reduced by -6.5% (from 36.4 to 29.9%) in T1Ds and by -10.8% (from 25.7 to 14.9%) in T2Ds. Mean glucose reduced on average by -11.4mg/dl (from 173.9 to 162.5mg/dl) in T1Ds and by -17.3mg/dl (from 156.8 to 139.5) in T2Ds. 2 to 3 sessions per week or 11 to 20 minutes per week on the OTR app improved readings in-range in T1Ds by 5% or 6%, respectively (see graphs below) . Similar trends were observed in people with T2D.

Conclusion: Real world data from nearly 7000 people with diabetes demonstrates significantly improved readings in-range and lower mean glucose in those using the OneTouch Verio Reflect® meter and OneTouch Reveal® app.


M. Grady: Employee; LifeScan. H. Cameron: None. E. H. Holt: Employee; Intarcia Therapeutics, Inc., LifeScan.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at